XMTT, Inc. v. Intel Corporation

CourtDistrict Court, D. Delaware
DecidedMay 12, 2020
Docket1:18-cv-01810
StatusUnknown

This text of XMTT, Inc. v. Intel Corporation (XMTT, Inc. v. Intel Corporation) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
XMTT, Inc. v. Intel Corporation, (D. Del. 2020).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

XMTT, INC., Plaintiff, v. Civil Action No. 18-cv-1810-RGA INTEL CORPORATION, Defendant.

MEMORANDUM OPINION

Brian E. Farnan, Michael J. Farnan, FARNAN LLP, Wilmington, DE; Morgan Chu, Ben Hattenbach (argued), Anthony Rowles (argued), Conor Tucker, IRELL & MANELLA LLP, Los Angeles, CA;

Attorneys for Plaintiff

Jack B. Blumenfeld, Jeremy A. Tigan, MORRIS, NICHOLS, ARSHT & TUNNELL LLP, Wilmington, DE; Paul A. Bondor (argued), Laurie N. Stempler (argued), Jeffrey S. Seddon, Michael Wueste, Priyanka R. Dev, Thomas J. Derbish, DESMARAIS LLP, New York, NY; Attorneys for Defendant

May 12, 2020 /s/ Richard G. Andrews ANDREWS, U.S. DISTRICT JUDGE:

Before the Court is the issue of claim construction of multiple terms in U.S. Patent Nos. 7,707,388 (“the ’388 patent”) and 8,145,879 (“the ’879 patent”). The Court has considered the Parties’ Joint Claim Construction Brief. (D.I. 79). The Court heard oral argument by videoconference on April 30, 2020. (D.I. 114). I. BACKGROUND Plaintiff filed this action on November 16, 2018, alleging infringement of the ’388 and ’879 patents. (D.I. 1). The asserted patents are directed to a “computer memory architecture for hybrid serial and parallel computing systems.” (D.I. 79 at 3; see ʼ388 patent at 1:25-27). II. LEGAL STANDARD “It is a bedrock principle of patent law that the claims of a patent define the invention to which the patentee is entitled the right to exclude.” Phillips v. AWH Corp., 415 F.3d 1303, 1312 (Fed. Cir. 2005) (en banc) (internal quotation marks omitted). “‘[T]here is no magic formula or catechism for conducting claim construction.’ Instead, the court is free to attach the appropriate weight to appropriate sources ‘in light of the statutes and policies that inform patent law.’” SoftView LLC v. Apple Inc., 2013 WL 4758195, at *1 (D. Del. Sept. 4, 2013) (quoting Phillips, 415 F.3d at 1324) (alteration in original). When construing patent claims, a court considers the literal language of the claim, the patent specification, and the prosecution history. Markman v.

Westview Instruments, Inc., 52 F.3d 967, 977–80 (Fed. Cir. 1995) (en banc), aff’d, 517 U.S. 370 (1996). Of these sources, “the specification is always highly relevant to the claim construction analysis. Usually, it is dispositive; it is the single best guide to the meaning of a disputed term.” Phillips, 415 F.3d at 1315 (internal quotation marks omitted). “[T]he words of a claim are generally given their ordinary and customary meaning. . . . [Which is] the meaning that the term would have to a person of ordinary skill in the art in question at the time of the invention, i.e., as of the effective filing date of the patent application.” Id. at 1312–13 (citations and internal quotation marks omitted). “[T]he ordinary meaning of a

claim term is its meaning to [an] ordinary artisan after reading the entire patent.” Id. at 1321 (internal quotation marks omitted). “In some cases, the ordinary meaning of claim language as understood by a person of skill in the art may be readily apparent even to lay judges, and claim construction in such cases involves little more than the application of the widely accepted meaning of commonly understood words.” Id. at 1314. When a court relies solely upon the intrinsic evidence—the patent claims, the specification, and the prosecution history—the court’s construction is a determination of law. See Teva Pharm. USA, Inc. v. Sandoz, Inc., 135 S. Ct. 831, 841 (2015). The court may also make factual findings based upon consideration of extrinsic evidence, which “consists of all evidence external to the patent and prosecution history, including expert and inventor testimony,

dictionaries, and learned treatises.” Phillips, 415 F.3d at 1317–19 (internal quotation marks omitted). Extrinsic evidence may assist the court in understanding the underlying technology, the meaning of terms to one skilled in the art, and how the invention works. Id. Extrinsic evidence, however, is less reliable and less useful in claim construction than the patent and its prosecution history. Id. “A claim construction is persuasive, not because it follows a certain rule, but because it defines terms in the context of the whole patent.” Renishaw PLC v. Marposs Societa’ per Azioni, 158 F.3d 1243, 1250 (Fed. Cir. 1998). It follows that “a claim interpretation that would exclude the inventor’s device is rarely the correct interpretation.” Osram GMBH v. Int’l Trade Comm’n, 505 F.3d 1351, 1358 (Fed. Cir. 2007) (citation and internal quotation marks omitted). III. CONSTRUCTION OF DISPUTED TERMS 1. “prior to a transition from a serial processing mode to a parallel processing mode”

a. Plaintiff’s proposed construction: “before a point in time when the plurality of parallel processors begin processing the software instructions in the software program from the serial processor and execute instructions in the software program in parallel”

b. Defendant’s proposed construction: “before the point in time when the plurality of parallel processors take over processing the software instructions in the software program from the serial processor and execute instructions in the software program in parallel” c. Court’s construction: “before the point in time when the plurality of parallel processors take over processing the software instructions in the software program from the serial processor and execute instructions in the software program in parallel”

Before the April 30, 2020 Markman hearing, Plaintiff agreed to Defendant’s construction for this term. (D.I. 84). Thus, I construe “prior to a transition from a serial processing mode to a parallel processing mode” to mean “before the point in time when the plurality of parallel processors take over processing the software instructions in the software program from the serial processor and execute instructions in the software program in parallel.” 2. “plurality of partitioned memory modules” 3. “plurality of shared memory modules”

a. Plaintiff’s proposed constructions: Term 2: “multiple memory modules each subdivided into multiple sub-units” Term 3: “multiple memory modules that are shared by multiple processors”

b. Defendant’s proposed construction: Both terms: “a plurality of memory modules shared across all parallel processors wherein each logical address resides in only one memory module”

c. Court’s constructions: Term 2: “multiple memory modules each subdivided into multiple sub-units” Term 3: “multiple memory modules that are shared by multiple processors” The asserted claims of the ’388 patent include the language “plurality of partitioned memory modules.” 1 The asserted claims of the ’879 patent contain similar but different language: “plurality of shared memory modules.” 2 Defendant argues that these two terms “are used interchangeably” and should have the same construction because they “mean the same thing in the context of the patents-in-suit.” (D.I. 79 at 26-27). Defendant asserts that “the claim language demonstrates that ‘partitioned’ and ‘shared’ memory modules are just two different names for the same structure, performing the same claimed functions.” (Id. at 28).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

National Ass'n of Manufacturers v. Taylor
582 F.3d 1 (D.C. Circuit, 2009)
OSRAM GmbH v. International Trade Commission
505 F.3d 1351 (Federal Circuit, 2007)
Curtiss-Wright Flow Control, Corp. v. Velan, Inc.
438 F.3d 1374 (Federal Circuit, 2006)
Thorner v. Sony Computer Entertainment America LLC
669 F.3d 1362 (Federal Circuit, 2012)
In Re David C. Paulsen
30 F.3d 1475 (Federal Circuit, 1994)
Glaxo Wellcome, Inc. v. Andrx Pharmaceuticals, Inc.
344 F.3d 1226 (Federal Circuit, 2003)
Apple, Inc. v. Ameranth, Inc.
842 F.3d 1229 (Federal Circuit, 2016)
Teva Pharm. United States, Inc. v. Sandoz, Inc.
135 S. Ct. 831 (Supreme Court, 2015)
Hormone Research Foundation, Inc. v. Genentech, Inc.
904 F.2d 1558 (Federal Circuit, 1990)

Cite This Page — Counsel Stack

Bluebook (online)
XMTT, Inc. v. Intel Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/xmtt-inc-v-intel-corporation-ded-2020.